The biopharma industry has a long way to go before it’s ready to embrace superior manufacturing models. Why?

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.

The December issue will feature our inaugural Innovation Awards, recognising the most exciting new technologies of 2015.

Prescription drug abuse has already reached epidemic proportions in the US – and other countries look set to follow the dangerous trend.

Personalized medicine looks set to transform the biopharma landscape, and will demand significant changes in production methods.

The true path to success as an entrepreneur is the ability to spot high impact problems – and to be fearless in the pursuit of great solutions.

Sitting Down With… Carsten Brockmeyer, CEO, Formycon, Germany.

How can we fight the global pandemic of falsified and substandard medicines?

Manufacturing is getting smarter; only a cross-discipline approach will ensure the success of tomorrow’s processes.

Are ancient texts hiding the answer to antibiotic resistance?